Clinical labs are exploring new business opportunities as consumers take more control of their healthcare and bypass their ...
The approval marks the eighth FDA-approved CDx indication for the company's PD-L1 IHC 22C3 pharmDx, Code SK006, test for use with Keytruda.
With the license, MeMed can offer its BV test, which is intended to distinguish between bacterial and viral infections, in Canada.
An initial $1.35 million has been deployed to the University of California, San Francisco, to initiate the program, with additional funding announcements forthcoming.
NEW YORK – Laboratory Corporation of America said in a filing with the US Securities and Exchange Commission on Friday that it has entered into an agreement for a term loan of $750 million. The ...
The test detects up to 25 viral and bacterial targets, including SARS-CoV-2, influenza, Bordetella pertussis, and RSV, in one patient sample.
The firms, based in the UK and in France, are collaborating to develop an ELISA assay for a novel biomarker of severe sepsis known as oxidized pentraxin 3, or ox-PTX3.
Last week, readers were most interested in a story about Pluslife's MiniDock MTB, the only test in WHO's new class designation for tuberculosis diagnostic tests.
The companies intend to reduce variability and rework by aligning high-quality slide preparation with reliable digitization.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results